Cited by 114Liver physiology and pathologyLiver Disease Diagnosis and TreatmentLiver Diseases and Immunity

The DOI matches its Crossref record; 342 of the 342 references it cites were found in a registry or an index.

Hepatic Stellate Cells and Liver Fibrosis

Puche, Juan E., Saiman, Yedidya, Friedman, Scott L.·2013·Comprehensive Physiology

DOI 10.1002/j.2040-4603.2013.tb00529.x

Open this paper in CoChat — free account

Abstract

Hepatic stellate cells are resident perisinusoidal cells distributed throughout the liver, with a remarkable range of functions in normal and injured liver. Derived embryologically from septum transversum mesenchyme, their precursors include submesothelial cells that invade the liver parenchyma from the hepatic capsule. In normal adult liver, their most characteristic feature is the presence of cytoplasmic perinuclear droplets that are laden with retinyl (vitamin A) esters. Normal stellate cells display several patterns of intermediate filaments expression (e.g., desmin, vimentin, and/or glial fibrillary acidic protein) suggesting that there are subpopulations within this parental cell type. In the normal liver, stellate cells participate in retinoid storage, vasoregulation through endothelial cell interactions, extracellular matrix homeostasis, drug detoxification, immunotolerance, and possibly the preservation of hepatocyte mass through secretion of mitogens including hepatocyte growth factor. During liver injury, stellate cells activate into alpha smooth muscle actin‐expressing contractile myofibroblasts, which contribute to vascular distortion and increased vascular resistance, thereby promoting portal hypertension. Other features of stellate cell activation include mitogen‐mediated proliferation, increased fibrogenesis driven by connective tissue growth factor, and transforming growth factor beta 1, amplified inflammation and immunoregulation, and altered matrix degradation. Evolving areas of interest in stellate cell biology seek to understand mechanisms of their clearance during fibrosis resolution by either apoptosis, senescence, or reversion, and their contribution to hepatic stem cell amplification, regeneration, and hepatocellular cancer. © 2013 American Physiological Society. Compr Physiol 3:1473‐1492, 2013.

Integrity signals

Registry

Crossref · 10.1002/j.2040-4603.2013.tb00529.x

Cites

342 of 342 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y. I., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,716
Liver fibrosis
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
Genomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Self-citation
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,687
Self-citation
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,067
Self-citation
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942

Show all 338 references

Research works printed but not linked: 8

Connolly MK, 2009, In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF‐alpha, J Clin Invest, 119, 3213
Friedman SL, 2002, Reversing hepatic fibrosis, Sci Med, 8, 194
10.1002/hep.1840380415 · DOI
Kojima S, 2000, Transcriptional activation of urokinase by the Kruppel‐like factor Zf9/COPEB activates latent TGF‐beta1 in vascular endothelial cells, Blood, 95, 1309
10.1016/j.cell.2008.06.049 · DOI · Paper page
Roderburg C, 2012, miR‐133a mediates TGF‐beta‐dependent de‐repression of collagen‐synthesis in hepatic stellate cells during liver fibrosis, J Hepatol
Tacke F, 2009, Monocytes and Macrophages as Cellular Targets in Liver Fibrosis, Inflamm Allergy Drug Targets
Friedman SL guest editor. Special issue on fibrosis.Biochim Biophys Acta.2013Mar 16. pii: S0925‐4439(13)00077‐X. doi: 10.1016/j.bbadis. · DOI

Sorted by citations

Targeting integrin pathways: mechanisms and advances in therapy
Pang, X., He, X., Qiu, Z., Zhang, H., Xie, R., Liu, Z., Gu, Y., Zhao, N., Xiang, Q., & Cui, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01259-6 · Cited by 1,275
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019) · Cells · doi:10.3390/cells8111419 · Cited by 837
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
Zhang, C.-Y., Yuan, W.-G., He, P., Lei, J.-H., & Wang, C.-X. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i48.10512 · Cited by 594
Recent insights into the pathogenesis of nonalcoholic fatty liver disease
Arab, J. P., Arrese, M., & Trauner, M. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043617 · Cited by 573
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Wang, X., Zheng, Z., Caviglia, J. M., Corey, K. E., Herfel, T. M., Cai, B., Masia, R., Chung, R. T., Lefkowitch, J. H., Schwabe, R. F., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.016 · Cited by 413
Orchestrating liver development
Gordillo, M., Evans, T., & Gouon-Evans, V. (2015) · Development · doi:10.1242/dev.114215 · Cited by 375
NKG2D ligands mediate immunosurveillance of senescent cells
Sagiv, A., Burton, D. G. A., Moshayev, Z., Vadai, E., Wensveen, F., Ben-Dor, S., Golani, O., Polic, B., & Krizhanovsky, V. (2016) · Aging · doi:10.18632/aging.100897 · Cited by 345
p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling
Yosef, R., Pilpel, N., Papismadov, N., Gal, H., Ovadya, Y., Vadai, E., Miller, S., Porat, Z., Ben‐Dor, S., & Krizhanovsky, V. (2017) · The EMBO Journal · doi:10.15252/embj.201695553 · Cited by 293
Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease
Wu, X., Fan, X., Miyata, T., Kim, A., Cajigas-Du Ross, C. K., Ray, S., Huang, E., Taiwo, M., Arya, R., Wu, J., et al. (2023) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-030435 · Cited by 289
Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
Cai, B., Dongiovanni, P., Corey, K. E., Wang, X., Shmarakov, I. O., Zheng, Z., Kasikara, C., Davra, V., Meroni, M., Chung, R. T., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.013 · Cited by 266
NLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice
Wree, A., McGeough, M. D., Inzaugarat, M. E., Eguchi, A., Schuster, S., Johnson, C. D., Peña, C. A., Geisler, L. J., Papouchado, B. G., Hoffman, H. M., et al. (2018) · Hepatology · doi:10.1002/hep.29523 · Cited by 266
The spatiotemporal program of zonal liver regeneration following acute injury
Ben-Moshe, S., Veg, T., Manco, R., Dan, S., Papinutti, D., Lifshitz, A., Kolodziejczyk, A. A., Bahar Halpern, K., Elinav, E., & Itzkovitz, S. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.04.008 · Cited by 224
Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis
Wang, X., Cai, B., Yang, X., Sonubi, O. O., Zheng, Z., Ramakrishnan, R., Shi, H., Valenti, L., Pajvani, U. B., Sandhu, J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.010 · Cited by 204
A human multi-lineage hepatic organoid model for liver fibrosis
Guan, Y., Enejder, A., Wang, M., Fang, Z., Cui, L., Chen, S.-Y., Wang, J., Tan, Y., Wu, M., Chen, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26410-9 · Cited by 149
Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease
Machado, M. V., Michelotti, G. A., Pereira, T. A., Xie, G., Premont, R., Cortez-Pinto, H., & Diehl, A. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.031 · Cited by 135
“In liver, as in most organs, tissue-resident myofibroblasts are the major sources of fibrous matrix [23].”
Natural killer cells and liver fibrosis
Fasbender, F., Widera, A., Hengstler, J. G., & Watzl, C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00019 · Cited by 118
Understanding the heterogeneity of resident liver macrophages
Blériot, C., & Ginhoux, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02694 · Cited by 107
Five‐year histological and serological follow‐up of operationally tolerant pediatric liver transplant recipients enrolled in WISP‐R
Feng, S., Demetris, A. J., Spain, K. M., Kanaparthi, S., Burrell, B. E., Ekong, U. D., Alonso, E. M., Rosenthal, P. J., Turka, L. A., Iklé, D. N., et al. (2016) · Hepatology · doi:10.1002/hep.28681 · Cited by 101
The m6A Reader IGF2BP2 Regulates Glycolytic Metabolism and Mediates Histone Lactylation to Enhance Hepatic Stellate Cell Activation and Liver Fibrosis
Zhou, Y., Yan, J., Huang, H., Liu, L., Ren, L., Hu, J., Jiang, X., Zheng, Y., Xu, L., Zhong, F., et al. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-06509-9 · Cited by 92
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease
Gao, H., Jiang, Y., Zeng, G., Huda, N., Thoudam, T., Yang, Z., Liangpunsakul, S., & Ma, J. (2024) · eGastroenterology · doi:10.1136/egastro-2024-100104 · Cited by 97
Single-Cell Transcriptomics Reveals Early Emergence of Liver Parenchymal and Non-parenchymal Cell Lineages
Lotto, J., Drissler, S., Cullum, R., Wei, W., Setty, M., Bell, E. M., Boutet, S. C., Nowotschin, S., Kuo, Y.-Y., Garg, V., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.012 · Cited by 86
Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2
Xu, Y., Zhao, W., Xu, J., Li, J., Hong, Z., Yin, Z., & Wang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.6839 · Cited by 81
MicroRNA‐21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis
Caviglia, J. M., Yan, J., Jang, M. K., Gwak, G., Affò, S., Yu, L., Olinga, P., Friedman, R. A., Chen, X., & Schwabe, R. F. (2017) · Hepatology · doi:10.1002/hep.29627 · Cited by 82
A small population of liver endothelial cells undergoes endothelial-to-mesenchymal transition in response to chronic liver injury
Ribera, J., Pauta, M., Melgar-Lesmes, P., Córdoba, B., Bosch, A., Calvo, M., Rodrigo-Torres, D., Sancho-Bru, P., Mira, A., Jiménez, W., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00428.2016 · Cited by 64
Wogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis
Du, X., Li, H.-D., Yang, X., Li, J., Xu, J., Chen, Y., Xu, Q., Yang, L., He, C.-S., Huang, C., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.056 · Cited by 64
NOD‐like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASH
Calcagno, D. M., Chu, A., Gaul, S., Taghdiri, N., Toomu, A., Leszczynska, A., Kaufmann, B. K., Papouchado, B. G., Wree, A., Geisler, L. J., et al. (2022) · Hepatology · doi:10.1002/hep.32320 · Cited by 62
Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions
Myint, M., Oppedisano, F., De Giorgi, V., Kim, B.-M., Marincola, F. M., Alter, H. J., & Nesci, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04627-0 · Cited by 61
Liver Sinusoidal Endothelial Cells
Sørensen, K. K., Simón-Santamaría, J., McCuskey, R. S., & Smedsrød, B. H. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140078 · Cited by 307
Porcine liver anatomy applied to biomedicine
Eberlova, L., Maleckova, A., Mik, P., Tonar, Z., Jirik, M., Mirka, H., Palek, R., Leupen, S., & Liska, V. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2019.12.038 · Cited by 45
Constructing biomimetic liver models through biomaterials and vasculature engineering
Lv, W., Zhou, H., Aazmi, A., Yu, M., Xu, X., Yang, H., Huang, Y. Y. S., & Ma, L. (2022) · Regenerative Biomaterials · doi:10.1093/rb/rbac079 · Cited by 45
Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway
Zhou, Q., Rong, C., Gu, T., Li, H., Wu, L., Zhuansun, X., Zhao, X., Xiao, Z., Kuang, Y., Xu, S., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03030-8 · Cited by 43
Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl4-induced hepatic fibrosis in rats in vivo
Wang, R., Zhang, D., Tang, D., Sun, K., Peng, J., Zhu, W., Yin, S., & Wu, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107151 · Cited by 39
Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver
Sojoodi, M., Erstad, D. J., Barrett, S. C., Salloum, S., Zhu, S., Qian, T., Colon, S., Gale, E. M., Jordan, V. C., Wang, Y., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.01.015 · Cited by 35
Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through P110δ‐dependent induction and expansion of regulatory T cells in mice
Khadem, F., Gao, X., Mou, Z., Jia, P., Movassagh, H., Onyilagha, C., GOUNNI, A. S., Wright, M. C., & Uzonna, J. E. (2015) · Hepatology · doi:10.1002/hep.28130 · Cited by 26
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
Callegari, E., Domenicali, M., Shankaraiah, R. C., D’Abundo, L., Guerriero, P., Giannone, F. A., Baldassarre, M., Bassi, C., Elamin, B. K., Zagatti, B., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.11.018 · Cited by 22
Role of PML SUMOylation in arsenic trioxide-induced fibrosis in HSCs
Dai, J., Hu, Y., Niu, Q., Song, G., Wang, H., & Li, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117607 · Cited by 22
AI‐Assisted Drug Re‐Purposing for Human Liver Fibrosis
Guan, Y., Cui, L., Inchai, J., Fang, Z., Law, J., Brito, A. A. G., Pawlosky, A., Gottweis, J., Daryin, A., Myaskovsky, A., et al. (2025) · Advanced Science · doi:10.1002/advs.202508751 · Cited by 25
Total phenolic extract of Euscaphis konishii hayata Pericarp attenuates carbon tetrachloride (CCl4)-induced liver fibrosis in mice
Huang, W., Zheng, Y., Feng, H., Ni, L., Ruan, Y.-F., Zou, X., Ye, M., & Zou, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109932 · Cited by 20
A three-year review (2023–2025) on the effectiveness of natural products from plants in treating major types of fibrosis
Kuete, J. B. T., Kuete, J. R. N., Mbaveng, A. T., Kuete, V., Efferth, T., & Weiskirchen, R. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157242 · Cited by 18
Zonation, Zonation, Zonation: The Real Estate of the Liver
Yasaka, T. M., Kim, C., Meadows, V., & Monga, S. P. (2025) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-042624-091820 · Cited by 28
Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway
Li, X., Chen, H., Yi, Z., Yanming, L., & Jianping, G. (2017) · Oncotarget · doi:10.18632/oncotarget.15472 · Cited by 20
Communication initiated by hepatocytes: The driver of HSC activation and liver fibrosis
Lan, R., Lin, J., Chen, S., Lü, Z., Gong, Y., Tan, S., Liu, X., & He, W. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000753 · Cited by 18
BMP7-Loaded Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorate Liver Fibrosis by Targeting Activated Hepatic Stellate Cells
Zhu, D., Sun, Z., Wei, J., Zhang, Y., An, W., Lin, Y., & Li, X. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s450284 · Cited by 17
The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial
Hansen, J. K., Israelsen, M. E., Nishijima, S., Stinson, S. E., Andersen, P., Johansen, S., Hansen, C. D., Brol, M. J., Klein, S., Schierwagen, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60755-9 · Cited by 14
Quantitative imaging of fibrotic and morphological changes in liver of non-alcoholic steatohepatitis (NASH) model mice by second harmonic generation (SHG) and auto-fluorescence (AF) imaging using two-photon excitation microscopy (TPEM)
Yamamoto, S., Oshima, Y., Saitou, T., Watanabe, T., Miyake, T., Yoshida, O., Tokumoto, Y., Abe, M., Matsuura, B., Hiasa, Y., et al. (2016) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2016.09.010 · Cited by 13
Uptake of Retinoic Acid‐Modified PMMA Nanoparticles in LX‐2 and Liver Tissue by Raman Imaging and Intravital Microscopy
Yildirim, T., Matthäus, C., Press, A. T., Schubert, S., Bauer, M. W., Popp, J., & Schubert, U. S. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201700064 · Cited by 13
Modifiers of Liver-Related Manifestation in the Course of NAFLD
Nasr, P., Blomdahl, J., Kechagias, S., & Ekstedt, M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200310142803 · Cited by 13
Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma
Affò, S., Sererols-Viñas, L., Garcia‐Vicién, G., Cadamuro, M., Chakraborty, S., & Sirica, A. E. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.07.009 · Cited by 12
Liver fibrosis with persistently normal alanine transaminase levels exhibits a distinct treatment response in MASLD
Luo, L., Shao, C., Teng, L., Zhuo, S., Dong, Z., Wang, W. J., Ye, J., & Zhong, B. (2025) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2025-001895 · Cited by 11
Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway
Wang, X., Liu, H., Wang, Y., Wang, P., Yi, Y., Lin, Y., & Li, X. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16538 · Cited by 13
Integration of network pharmacology and serum medicinal chemistry to investigate the pharmacological mechanisms of QiZhuYangGan decoction in the treatment of hepatic fibrosis
Deng, J.-W., Yuan, S., Shi, L.-P., Chen, X., Liu, J., Chen, Z.-W., Tan, K.-Y., Yang, Q., & Cao, W.-F. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117730 · Cited by 12
AMPK maintains the activation of hepatic stellate cells through mitophagy-induced metabolic reprogramming
Wang, H., Wang, G., Yin, T., Li, H., Wang, H., Shao, Y., Li, Y., Hua, R., Li, J., & Zang, Y. (2025) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaf030 · Cited by 11
Mechanistic insights into post-translational modifications in hepatic fibrosis: pathogenic roles and therapeutic potentials
Bai, X., Liu, Z., Li, X., Sun, R., & Yu, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07037-6 · Cited by 10
Comparative study of liver injury protection by Akkermansia muciniphila and Faecalibacterium prausnitzii interventions in live and cell-free supernatant forms via targeting the hepcidin – ferroportin axis in mice with CCl₄-induced liver fibrosis
Badi, S. A., Aval, H. T., Moradi, H. R., Malek, A., Seyedi, S. A., Davari, M., Bereimipour, A., Khani, S., Khatami, S., & Siadat, S. D. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00728-x · Cited by 10
From signaling pathways to clinical trials: mesenchymal stem cells as multimodal regenerative architects in liver cirrhosis therapy
Bozorgi, V., Babaahmadi, M., Salehi, M., Vafaeimanesh, J., & Hajizadeh-Saffar, E. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04535-8 · Cited by 11
“Activated HSCs overexpress tissue inhibitors of metalloproteinases (TIMPs), which inhibit key matrix-degrading enzymes (MMP-2, MMP-9, MMP-13), thereby preventing ECM degradation and promoting scar accumulation [35, 36].”
Ginsenoside compound K restrains hepatic fibrotic response by dual-inhibition of GLS1 and LDHA
Wu, W., Yang, Y., Wang, T., Sun, X., Wei, M., Zhou, X.-Y., Zhu, L.-Z., Ma, G., Liu, B., Qi, L., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156223 · Cited by 9
Current Therapeutic Targets for Alcohol-Associated Liver Disease
Zhang, M., Ji, J., Song, J., An, C., Pei, W., Fan, Q., Zuo, L., & Wang, H. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.06.009 · Cited by 9
Regression of Liver Fibrosis
Guido, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-42873-6.00040-8 · Cited by 10
Single-cell profiling reveals monocyte heterogeneity and association with liver fibrosis in patients with chronic HBV
Zhuo, Y., Wu, H., Zhao, W., Yin, S., Lei, F., Pang, X., Sun, W., Feng, L., Jia, S., Li, W., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000672 · Cited by 8
Human pluripotent stem cell-derived fetal hepatic stellate cells promote vascularization and maturation in liver organoids
Yang, X., Nie, Y., Lu, C., Li, Y., Hayashi, Y., Plummer, R., Luo, N., Li, Q., Kasai, T., Okumura, T., et al. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.09.002 · Cited by 11
Macrophage-derived CCL1 targets CCR8 receptor in hepatic stellate cells to promote liver fibrosis through JAk/STAT pathway
Diao, S., Li, L., Zhang, J., Ji, M.-L., Sun, L., Shen, W., Wu, S., Chen, Z., Huang, C., & Li, J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116884 · Cited by 7
Notoginsenoside R2 attenuates hepatic fibrosis via STAT3-dependent hepatic stellate cells senescence induction and inflammatory microenvironment suppression
Deng, K., Li, M., Li, Y., Xiang, L., Wang, Y., Shi, H., Cheng, J., Huang, S., & Lv, Z. (2025) · Journal of Ginseng Research · doi:10.1016/j.jgr.2025.05.007 · Cited by 5
Lactate dehydrogenase inhibitors: A promising candidate against aging and fibrosis
Luo, W., Wang, G., Li, H., Guo, S., Zhao, C., Cao, Z., Pan, Z., Jiang, Z., Fan, H., Liu, L., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118377 · Cited by 5
Liver-on-a-Chip (LoC) Models: Case Studies of Academic Platforms and Commercial Products
Benzait, Z., Tomsuk, Ö., Ebrahimi, A., Ghorbanpoor, H., Özel, C., Didarian, R., Cevizlidere, B. D., Kaya, M., Gür, T., Gasimzade, N., et al. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01122 · Cited by 6
Magnoflorine ameliorates hepatic fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway
Zhang, M., Xu, L., Zhu, C., Zhang, Y., Luo, R., Ren, J., Yu, J., Zhang, Y., Liang, G., & Zhang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39892 · Cited by 5
Nutraceutical benefits of seaweeds and their phytocompounds: a functional approach to disease prevention and management
Kahwa, I., Omara, T., Ayesiga, I., Shah, K., Ambe, G. N. N. N., Panwala, Z. J., Mbabazi, R., Iqbal, S., Kyarimpa, C. M., Nagawa, C. B., et al. (2025) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.14287 · Cited by 7
Hepatic stellate cell inhibition by angiotensin II receptor blocker mitigates liver injury and fibrosis via NF-κB-galectin-3 suppression in a rat nonalcoholic steatohepatitis model
Kuang, X., Naiki‐Ito, A., Kawamura, H., Murakami, A., Komura, M., Kato, H., Nagayasu, Y., & Takahashi, S. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04075-3 · Cited by 4
Orosomucoid 1 Ameliorates Temporomandibular Joint Osteoarthritis by Maintaining Cartilage Homeostasis
Zhang, D., Zhang, Y., Xia, S., Chen, L., Shen, P., & Yang, C. (2025) · Advanced Science · doi:10.1002/advs.202500028 · Cited by 4
18β-Glycyrrhetinic acid mitigates adverse effects of high-fat diets on liver fibrosis in largemouth bass (Micropterus salmoides) by reducing mitochondrial Ca2+ level
Zhao, J., Liu, H., Yang, Z., He, L., Shan, H., Faggio, C., Cao, Q., & Jiang, J. (2025) · Animal nutrition · doi:10.1016/j.aninu.2025.05.010 · Cited by 4
Decoding cellular stress states for toxicology using single-cell transcriptomics
Shah, I., Gallegos, D. A., Robinette, B., Chambers, B. A., Eastburn, D. J., Bell, D. A., Campbell, M. R., Martos, S. N., Camiolo, S., White, K. S., et al. (2025) · NAM journal. · doi:10.1016/j.namjnl.2025.100046 · Cited by 3
Nanoparticle: Pathogenesis, Innovative Diagnosis, and Therapy of Liver Fibrosis
Wen, L., Liu, X., Yang, D., Sun, Z., Liang, C., Wu, J., Xie, L., Xing, R., & Li, X. (2025) · ChemistrySelect · doi:10.1002/slct.202500446 · Cited by 5
The Effects of Extracellular Vesicles Derived from Hydatid Cyst Fluid on the Expression of microRNAs Involved in Liver Fibrosis
Rahimi, H. M., Mahdavi, F., Eslami, N., Nemati, S., & Mirjalali, H. (2025) · Acta Parasitologica · doi:10.1007/s11686-025-01024-z · Cited by 3
Hepatic ferroptosis induced by Clonorchis sinensis exacerbates liver fibrosis
Zhang, H., Wang, X., Zhang, X., Ma, Y., Bao, P., Yu, Y., Wang, Y., Gong, P., Zhang, N., Lee, S.-O., et al. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013164 · Cited by 5
Structure, Function and Responses to Injury
Crawford, J. M., Bioulac‐Sage, P., & Hytiroglou, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00001-6 · Cited by 3
Triclosan exposure induces liver fibrosis in mice: The heterogeneous nuclear ribonucleoprotein A1/pyruvate kinase M2 axis drives hepatic stellate cell activation
NI, X. Y., Wei, Z., Peng, Y., Zheng, L., Shang, J., Liu, F., Li, Y., & Liu, J. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118113 · Cited by 4
Hepatocyte cellular repressor of E1A-stimulated genes 1 protects against acetaminophen-induced liver injury by promoting autophagy
Cheng, Q.-Y., Wu, M., Wei, X., Lu, L., Liu, R., Li, Y.-H., Zhu, N.-N., Li, Y.-Q., Zuo, L., & Wang, H. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01532-8 · Cited by 2
Bone marrow MSCs-derived exosomes (BM-MSCs-Exo) expressed mir-181, mir-24, mir-9, mir-29, mir-338, and mir-486 ameliorated hepatic fibrosis in male rats via altering the expression of Menin-1/TGF-β/smad pathway
Khamis, T., Ibrahim, A. A. E. W., Ali, L. S., El‐Shal, A. S., Abdallah, S. H., Alanazi, A., Abdellatif, H., Salah, W., Kashgari, F. A., Halloull, N. M., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178209 · Cited by 2
Nuclear Factor I‐B Delays Liver Fibrosis by Inhibiting Chemokine Ligand 5 Transcription
Chen, Q.-Q., Rui, F.-J., Fan, Z., Yang, H.-J., Geng, N., Lu, C.-Q., Ni, W.-J., Huan, Y., Shi, J.-P., Wu, C., et al. (2025) · Advancement of science · doi:10.1002/advs.202511311 · Cited by 3
Hepatitis Due to Hepatotropic Viruses
Guido, M., Mangia, A., & Theise, N. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00006-5 · Cited by 2
Anatomy and histopathology of the liver
Crawford, J. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-26710-9.00001-8 · Cited by 2
Allopurinol abates hepatocellular carcinoma in rats via modulation of NLRP3 inflammasome and NF-κB pathway
Bahriz, H. A., Abdelaziz, R. R., & El‐Kashef, D. H. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03666-8 · Cited by 2
Comprehensive review of the vascular niche in regulating liver regeneration, fibrosis, and hepatocellular carcinoma
Chen, Y., Zhou, Y., Li, P., & Ding, B. (2025) · EngMedicine · doi:10.1016/j.engmed.2025.100070 · Cited by 1
Mechanistic evaluation of a traditional herbal decoction in attenuating hepatic fibrosis via Nrf2/GPX4 pathway activation and ferroptosis inhibition
Liu, J., Zhou, X., Zhou, J., Tong, L.-J., Hu, L., Liu, X., Hu, L., Zhou, C., & Dai, Q. (2025) · Hereditas · doi:10.1186/s41065-025-00471-y · Cited by 1
Tadehaginoside improves liver fibrosis in mice by inhibiting the activation of hepatic stellate cells mediated by the molecular axis of miR-155/FOXO3
Tang, A., Wei, L., Gao, J., Zhang, Z., Xia, B., Li, X., & Lu, Q. (2025) · Drug and Chemical Toxicology · doi:10.1080/01480545.2025.2527178 · Cited by 1
Alantolactone mitigates thioacetamide-induced liver fibrosis in mice by inhibiting TLR4/MyD88/NF-κB axis
Almukadi, H. S., Alotaibi, N. N., Shaik, R. A., Abdel‐Naim, A. B., Esmat, A., & Eid, B. G. (2025) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/apjtb.apjtb_254_25 · Cited by 1
Fabrication of Millimeter-Sized Three-Dimensional In Vitro Tissues with High Cellular Density and Hierarchical Vascular Networks
Wu, P., Yokota, K., Yasuma, N., Hakamada, M., & Mabuchi, M. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01685 · Cited by 1
Design, Synthesis, and Anti-Hepatic Fibrosis Evaluation of Cordycepin Derivatives
Pan, W.-F., Liu, S., Zhong, Y.-C., Tang, B.-X., Zang, Y., & Xie, Y. (2026) · Molecules · doi:10.3390/molecules31020264 · Cited by 1
Micro/nanoplastics and lithium iron phosphate at environmentally relevant dose triggers hepatic fibrosis: Unseen risks of global renewable energy
Xia, P., Shen, R., Zhang, X., Yan, Z., Zhou, S., Tan, H., Zhang, Y., Chen, D., & Deng, Y. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.142199 · Cited by 1
Hepatocyte CREBZF-osteopontin axis controls fibrosis in nonalcoholic steatohepatitisPreprint
Ma, F., Liu, Y., Hu, Z., Xue, Y., Liu, Z., Cai, G., Su, W., Zheng, Z., Ding, D., Sun, X., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-929976/v1
Hepatic Nonparenchymal Cells and Liver-Associated Lymphoid Cells
Gardner, C. R., Laskin, J. D., & Laskin, D. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00250-3
Amphiphilic lipid-peptide engineered placenta-derived mesenchymal stem cells for liver fibrosis treatment
Park, H. W., Lee, D. H., Kim, S., Park, H., Jangid, A. K., Lee, C. E., Park, J., Park, G. T., Park, H. Y., Kim, H., et al. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101061
Multimaterial printing for medical design
Renter, W. J., Habib, A. K. M. A., Khalil, M., Tomori, M., Khatri, N. R., & Egan, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29228-6.00017-7
Nanomedicines to alleviate hepatic metabolic disorders
Baidya, A., Ghosh, I., Sar, S., Banerjee, T., Kumar, A., Saha, S., Chaki, R., Halder, A. K., & Ghosh, N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-28942-2.00007-7
Specific clinicopathologic findings are associated with the severity and chronicity of drug-induced liver injury among hospitalized patients
Zhang, T., Li, M., Ge, Y., Teng, X., Zhao, H., Wang, H., Zhou, X., & Xie, W. (2025) · npj gut and liver. · doi:10.1038/s44355-025-00027-x
A hepatocyte membrane-based culture system recapitulating the physiological microenvironment of hepatic stellate cells
Inoue, K., Matsubara, T., Urushima, H., Yuasa, H., Daikoku, A., Ikeda, K., Kawada, N., Yoshizato, K., Suzuki, T., & Sato-Matsubara, M. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00803.2025
Autophagy-mediated Kupffer cell polarization in liver cirrhosis reversal: Mechanistic insights and therapeutic strategies
Sur, D., & Banik, G. (2026) · Liver Research · doi:10.1016/j.livres.2026.01.001
Rôle des cellules endothéliales dans le carcinome hépatocellulaire associé au syndrome métabolique
Laouirem, S. (2019) · theses.fr (ABES) · doi:10.70675/8139d5c7zb3b1z466az837az2b9408b374a8
Rôle de LECT2 dans les maladies stéatosiques non alcooliques du foie
Pham, S. (2020) · theses.fr (ABES) · doi:10.70675/3693bfe6z9d91z4045za9a9zc37497dc9c1b
Rôle du récepteur nucléaire CAR dans la pathogénèse dimorphique de la NAFLD (Non-Alcoholic Fatty Liver Disease), induite par un régime gras ou par l'exposition à des contaminants alimentaires
Oliviero, F. (2021) · theses.fr (ABES) · doi:10.70675/59e48d7ezf6c4z4d80za13czb4e84b35e3dc
Impact de la stéatohépatite non alcoolique sur le remodelage myocardique et sur les complications cardiovasculaires
Decoin, R. (2023) · theses.fr (ABES) · doi:10.70675/86ee210fz0966z4d73zaab2z3d0fa1adefed

Authors: Puche, J. E., Saiman, Y., & Friedman, S. L.
Affiliations: Universidad San Pablo CEU (ES)
Mount Sinai Hospital (US)
Corresponding author: Friedman, Scott L.
ORCID: Puche, Juan E.
Saiman, Yedidya
Friedman, Scott L.
Venue: Comprehensive Physiology
Publisher: Wiley
Published: 2013-10
Volume: 3
Issue: 4
Pages: 1473-1492
ISSN: 2040-4603 (ISSN-L)
DOI: 10.1002/j.2040-4603.2013.tb00529.x
OpenAlex: W4409095387
Cited by: 89
References: 338
Citations by year: 2026: 19 · 2025: 38 · 2024: 7 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 5 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 2
FWCI: 1.25
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
Locations: Comprehensive physiology (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Keywords: hepatic stellate cells, liver fibrosis, stellate cell activation, alpha-smooth muscle actin, myofibroblasts, intermediate filaments, extracellular matrix homeostasis, connective tissue growth factor, TGF-β1, fibrosis resolution, hepatocyte growth factor, portal hypertension, liver regeneration, hepatocellular carcinoma, liver injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hepatic Stellate Cells and Liver Fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks